BK vs. PFE
Compare and contrast key facts about The Bank of New York Mellon Corporation (BK) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BK or PFE.
Correlation
The correlation between BK and PFE is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BK vs. PFE - Performance Comparison
Loading data...
Key characteristics
BK:
2.35
PFE:
-0.65
BK:
3.05
PFE:
-0.69
BK:
1.45
PFE:
0.92
BK:
3.32
PFE:
-0.24
BK:
12.38
PFE:
-1.03
BK:
4.71%
PFE:
13.71%
BK:
24.58%
PFE:
24.45%
BK:
-72.42%
PFE:
-58.96%
BK:
0.00%
PFE:
-55.78%
Fundamentals
BK:
$63.95B
PFE:
$128.49B
BK:
$6.13
PFE:
$1.42
BK:
14.58
PFE:
15.92
BK:
1.17
PFE:
0.57
BK:
3.40
PFE:
2.06
BK:
1.69
PFE:
1.42
BK:
$18.60B
PFE:
$62.46B
BK:
$18.53B
PFE:
$42.09B
BK:
$7.22B
PFE:
$16.71B
Returns By Period
In the year-to-date period, BK achieves a 18.63% return, which is significantly higher than PFE's -10.86% return. Over the past 10 years, BK has outperformed PFE with an annualized return of 10.33%, while PFE has yielded a comparatively lower 0.61% annualized return.
BK
18.63%
19.70%
16.42%
57.22%
26.80%
10.33%
PFE
-10.86%
5.56%
-4.64%
-15.78%
-4.34%
0.61%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BK vs. PFE — Risk-Adjusted Performance Rank
BK
PFE
BK vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for The Bank of New York Mellon Corporation (BK) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
BK vs. PFE - Dividend Comparison
BK's dividend yield for the trailing twelve months is around 2.09%, less than PFE's 7.45% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BK The Bank of New York Mellon Corporation | 2.09% | 2.32% | 3.04% | 3.12% | 2.24% | 2.92% | 2.34% | 2.21% | 1.60% | 1.52% | 1.65% | 1.63% |
PFE Pfizer Inc. | 7.45% | 6.33% | 5.70% | 3.12% | 2.64% | 3.91% | 3.67% | 3.11% | 3.53% | 3.69% | 3.46% | 3.33% |
Drawdowns
BK vs. PFE - Drawdown Comparison
The maximum BK drawdown since its inception was -72.42%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for BK and PFE. For additional features, visit the drawdowns tool.
Loading data...
Volatility
BK vs. PFE - Volatility Comparison
The current volatility for The Bank of New York Mellon Corporation (BK) is 4.83%, while Pfizer Inc. (PFE) has a volatility of 9.58%. This indicates that BK experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
BK vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between The Bank of New York Mellon Corporation and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BK vs. PFE - Profitability Comparison
BK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The Bank of New York Mellon Corporation reported a gross profit of 4.68B and revenue of 4.69B. Therefore, the gross margin over that period was 99.8%.
PFE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a gross profit of 10.87B and revenue of 13.72B. Therefore, the gross margin over that period was 79.3%.
BK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The Bank of New York Mellon Corporation reported an operating income of 1.49B and revenue of 4.69B, resulting in an operating margin of 31.8%.
PFE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported an operating income of 2.79B and revenue of 13.72B, resulting in an operating margin of 20.3%.
BK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The Bank of New York Mellon Corporation reported a net income of 1.22B and revenue of 4.69B, resulting in a net margin of 26.0%.
PFE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Pfizer Inc. reported a net income of 2.97B and revenue of 13.72B, resulting in a net margin of 21.6%.